Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
Lupus
|
November 1, 2018
Cell-bound complement activation products (CB-CAPs) have high sensitivity and specificity in pediatric-onset systemic lupus erythematosus and correlate with disease activity
J S Hui-Yuen, Y Gartshteyn, M Ma, et al.
Clinical Pharmacology and Therapeutics
|
August 8, 2008
Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia
G Stocco, M H Cheok, K R Crews, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 30, 2001
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia
J G Blanco, T Dervieux, M J Edick, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
Lupus
|
November 1, 2018
Cell-bound complement activation products (CB-CAPs) have high sensitivity and specificity in pediatric-onset systemic lupus erythematosus and correlate with disease activity
J S Hui-Yuen, Y Gartshteyn, M Ma, et al.
Clinical Pharmacology and Therapeutics
|
August 8, 2008
Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia
G Stocco, M H Cheok, K R Crews, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 30, 2001
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia
J G Blanco, T Dervieux, M J Edick, et al.
Page
of 2